The cardio-ankle vascular index (CAVI) has been proposed as a new noninvasive marker of arterial stiffness independent of blood pressure. We investigated the association of the CAVI with coronary atherosclerosis and left ventricular (LV) systolic and diastolic function in patients with ischemic heart disease (IHD). 
with left ventricular (LV) structure and LV function, particularly diastolic dysfunction, has been evaluated in patients with hypertension and diabetes 10, 11) . Although LV ejection fraction (LVEF) has been shown to be a significant predictor of adverse cardiac events in patients with ischemic heart disease (IHD) 12) , only a few studies have reported the effect of aortic stiffness on LV systolic function in IHD patients 13) . Stiffness parameter is based on the change in vascular diameter corresponding to arterial pressure variance, and the value does not depend on blood pressure 14) . Recently, an arterial stiffness parameter, termed the cardio-ankle vascular index (CAVI), has been developed as a marker of vascular properties, including the aorta, femoral artery and tibial artery 15) by combining two indices: stiffness parameter 16) and BramwellHill's formula 17) . Previous studies showed that CAVI was weakly correlated with systolic blood pressure and the measurement does not require special techniques 15, 18, 19) . Emerging data indicate that CAVI is useful to detect carotid and coronary atherosclerosis [20] [21] [22] [23] .
In the present study, we measured CAVI in patients with suspected coronary artery disease who underwent coronary angiography. Accordingly, the relationship of CAVI to coronary atherosclerosis, LV systolic function, and LV diastolic function determined by echocardiography was evaluated in IHD patients.
Methods

Study Population
We enrolled 206 consecutive subjects (159 men and 47 women; mean age: 67 12 years) undergoing coronary angiography (CAG) for the assessment of suspected coronary artery disease at Sumitomo Besshi Hospital (Niihama, Japan) from January 2007 to October 2008. All subjects were examined by CAVI measurement and echocardiography before CAG. The subjects were divided into two groups on the basis of the CAG findings: patients with significant coronary stenosis defined as 50% or greater luminal diameter narrowing (n 133) and without significant coronary stenosis (n 73).
Exclusion criteria were as follows: (1) patients with restrictive cardiomyopathy and hypertrophic cardiomyopathy on echocardiography (2) patients with clinically significant valvular disease and a prosthetic valve; (3) renal insufficiency (serum creatinine, more than 1.5 mg/dL); (4) patients with acute coronary syndrome or cor pulmonale; (5) patients with atrial fibrillation; and (6) peripheral arterial disease as evidenced by an ankle-brachial index of less than 0.9. Hypertension was diagnosed in accordance with the 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension 24) . Diabetes was defined as a fasting blood glucose level 126 mg/dL or requiring anti-diabetic medication. Dyslipidemia was diagnosed according to the 2007 Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 25) . This study protocol complied with the Declaration of Helsinki and was approved by the ethics committee of Sumitomo Besshi Hospital. Informed consent was obtained from all patients before the study.
Coronary Angiography
Coronary angiography was performed according to standard methods. After intracoronary injection of isosorbide dinitrate, angiograms were obtained in two or more views. The coronary angiogram was scored by two independent investigators and according to three techniques. (1) Vessel score: The number of vessels with significant stenosis, defined as 50% or greater luminal diameter narrowing 26) . (2) Stenosis score: A modified Gensisni score, which has been previously reported 27, 28) . Briefly, the most severe stenosis in each of eight segments was graded according to severity, from 1 to 4. The scores in each of the eight segments were added to give a total score out of 32. (3) Extent score: According to the proportional length of each vessel segment in the coronary artery tree, segments were graded with different maximum numbers of points, as previously reported. The scores of each vessel were added to give a total score out of 100 29) .
Cardio-Ankle Vascular Index
After a 5-min rest and with the subject seated, brachial blood pressure was measured using an automatic cuff oscillometric device, and the average of two readings was used to determine systolic pressure, diastolic pressure, and pulse pressure. CAVI was measured automatically using a VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan), as previously described 15, 30) . Briefly, cuffs were applied to bilateral upper arms and ankles, with the subjects lying supine and the head held in the midline position. After resting for 10 min, the examination was performed. Pulse wave velocity (PWV) was calculated by dividing the distance from the aortic valve to the ankle artery by the sum of the time between the aortic valve closing sound and the notch of the brachial pulse wave, and the time between the rise of the brachial pulse wave and rise of the ankle pulse wave. CAVI was determined using the following equation:
where Ps and Pd are systolic and diastolic blood pressures, respectively, PWV is the pulse wave velocity between the heart and ankle, P is Ps Pd, is blood density, and a and b are constants. The average of right and left CAVI was used for analysis.
Transthoracic Echocardiography
Comprehensive examinations were performed, including M-mode, two-dimensional conventional Doppler, and color Doppler echocardiography 31) . Measurements were made according to the guidelines laid down by the American Society of Echocardiography 32) . The left atrial dimension (LAD) was measured from M-mode images according to standard criteria. The LV mass index was calculated as left ventricular mass divided by the body surface area 33) . Using pulsed Doppler echocardiography, the LV diastolic filling pattern was recorded from the apical transducer position with the sample volume situated between the mitral leaflet tips. Peak early diastolic velocity (E velocity) and peak atrial diastolic velocity (A velocity) were recorded, and the ratio of E to A (E/A) was calculated. The deceleration time of E velocity (DcT) was measured as the time interval from the E-wave peak to the decline of velocity to baseline values. The LV isovolumetric relaxation time (IVRT) was taken as the time in milliseconds from the end of ejection fraction to the onset of LV filling. Experienced cardiologists blinded to CAVI interpreted all echocardiograms.
Echo Classifications of Diastolic Function
The subjects with preserved LV systolic function with ejection fraction ≥ 55% were divided into two groups according to LV diastolic function determined by the LV filling pattern. Impaired LV diastolic function was defined as impaired relaxation, and a pseudonormal and restrictive pattern based on the mitral inflow profile, including the E/A ratio and DcT, as described by Redfield et al. 
Statistical Analysis
Data are shown as the mean standard deviation. Categorical variables were compared between groups by chi-square analysis. The unpaired Student's test was used for continuous variables between groups. The difference in CAVI between groups was evaluated by analysis of covariance using confounding factors (ANCOVA). Differences in characteristics among groups were compared by one-way analysis of variance (ANOVA), followed by the Bonferroni post-hoc test for continuous variables. Relationships between variables were tested by Pearson and Spearman correlations. Factors independently associated with CAVI were assessed using univariate and multivariate liner regression analysis. Multivariate logistic analysis was performed to evaluate the relationship between the presence of LV diastolic dysfunction and CAVI, and the following factors were included: age, diabetes, use of calcium channel blockers and statins, systolic blood pressure, vessel score, and CAVI. A value of p 0.05 was considered significant. Data were analyzed using SPSS 11.0 for Windows (SPSS Inc., Chicago, IL). Table 1 shows the clinical characteristics and echocardiographic parameters in patients with and Values are expressed as numbers with percentages in parentheses or as the mean SD. p, probability value; BMI, body mass index; MI, myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; LAD, left atrial diameter; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; E/A, ratio of peak early transmitral velocity and peak transmitral atrial velocity; DcT, deceleration time of E velocity; CAVI, cardio-ankle vascular index without IHD. Dyslipidemia and diabetes were more prevalent in IHD patients, while systolic and diastolic blood pressures were comparable between groups. Patients with prior myocardial infarction were included in 41% of subjects with IHD. Echocardiographic findings showed that the LVEF in patients with IHD was significantly lower than in patients without IHD, while there were no significant differences in LAD, LV mass index, E/A, and DcT between groups. CAVI in patients with IHD was significantly higher than in patients without IHD, and this difference remained significant after adjustment for the presence of dyslipidemia, diabetes, prior myocardial infarction, and LVEF (9.2 0.1 vs. 8.7 0.2, as expressed mean SE, p 0.03, respectively). Table 2 shows univariate analysis regarding the association of CAVI with other parameters in all IHD patients and in sub-groups classified by LVEF, respectively. In all IHD patients, CAVI was significantly correlated with age, LDL-cholesterol, LV mass index, E/A, and angiographic scores of coronary atherosclerosis, besides LVEF. Fig. 1A also demonstrated the negative correlation between CAVI and LVEF. In the sub-group of IHD patients with preserved LVEF (LVEF ≥ 55%), univariate analysis demonstrated that CAVI was associated with echocardiographic parameters regarding LV diastolic function, such as E/A, DcT, and LV mass index, along with age, systolic blood pressure, pulse pressure, and angiographic scores of coronary atherosclerosis. In the sub-group of IHD patients with reduced LVEF (LVEF 55%), univariate analysis showed that CAVI was correlated with only angiographic scores of coronary atherosclerosis. The association between CAVI and LVEF did not reach statistical significance in analyses of sub-groups according to LVEF.
Results
Comparison of CAVI and Characteristics in Patients with and without IHD
Relationship between CAVI and Clinical Characteristics in IHD Patients
Furthermore, in all IHD patients, multivariate analysis was performed and CAVI was shown to be independently associated with age ( 0. remain significant in multivariate analysis. Fig. 1B, 1C and 1D demonstrate the association between CAVI and the development of coronary atherosclerosis determined with coronary angiography. CAVI gradually increased with the vessel, stenosis, and extent scores in all IHD patients, respectively.
Clinical Parameters in IHD Patients According to EF Tertiles
To assess factors associated with LV systolic function, patients with IHD were classified into tertiles on the basis of LVEF ( Table 3) . Patients in the lowest LVEF tertile (the most reduced LVEF) had smaller BMI, a lower prevalence of dyslipidemia, and a higher presence of prior myocardial infarction, larger LAD, and greater LV mass index than those in the highest LVEF tertile. CAVI in the lowest LVEF tertile was shown to be significantly greater than in the highest EF tertile. Table 4 shows the results of stepwise analysis. CAVI, as well as prior myocardial infarction, the LV mass index, and LAD were selected as independent factors associated with LVEF in patients with IHD.
LV Diastolic Dysfunction and CAVI in Patients with Preserved LVEF
To evaluate the relationship between LV diastolic dysfunction and CAVI, patients with preserved LVEF (n 96) were divided into two groups on the basis of the manifestation of normal (n 66) or impaired (n 30) LV diastolic function by echocardiography. As shown in Table 5 , there was a difference in the prevalence of diabetes, the use of calcium channel blockers, the use of statins, systolic blood pressure, pulse pressure, vessel score, and CAVI between groups. CAVI in patients with impaired LV diastolic function was significantly higher than in subjects with normal LV diastolic function, and this difference remained significant after adjustment for confounding factors (9.3 (48) 18 (41) 30 (68) 11 (25) 20 (53) 15 (35) 17 (43) 5 (14) 8 (18) 27 (60) 32 (71) 20 (44) 18 (40) 18 (41) 25 (57) 16 (36) 10 (23) 2 (4) 3 (7) 20 (44) 30 (68) 34 (77) 19 (43) 7 (16) 12 (27) 24 (56) 17 (39) 12 (28) 1 (2) 4 (9) 27 (61) For analysis, the following variables were included: age, gender, body mass index, history of smoking and prior MI, use of digitalis, LDL-cholesterol, systolic blood pressure, pulse pressure, LAD, LV mass index, vessel score, and CAVI. 0.2 vs. 8.7 0.1, expressed as the mean SE, p 0.02, respectively). Furthermore, multiple logistic analysis, including age, diabetes, use of calcium channel blockers and statins, systolic blood pressure, vessel score, and CAVI, revealed that an increase in CAVI was independently related with LV diastolic dysfunction. The adjusted odds ratio of LV diastolic dysfunction was 1.67 (95% confidential interval: 1.07 to 3.26) for each index of CAVI increase (p 0.03) (data not shown).
Discussion
The present study demonstrated that CAVI, a new parameter of arterial stiffness, was higher in patients with IHD than in patients without IHD. In addition, CAVI was independently associated with not only LV systolic dysfunction in all IHD patients, but also LV diastolic dysfunction, as assessed by echocardiography in IHD patients with preserved LVEF.
Among several markers of arterial stiffness, CAVI has been theoretically proposed as a new noninvasive estimation of , which is independent of blood pressure 15) . Previous studies showed that the contribution of blood pressure to CAVI was weaker than brachialankle PWV 15, 18, 23) . Our finding also supported the weak correlation between CAVI and systolic, diastolic, and pulse pressure in suspected IHD patients undergoing coronary angiography. In addition, recent studies showed that CAVI was associated with carotid and coronary atherosclerosis. Thus, emerging data suggest that CAVI would be promising tool for atherosclerosis screening in the clinical setting. On the other hand, CAVI essentially represents stiffness of the aorta, femoral artery and tibial artery as a whole 15) . Although a study demonstrated that of the thoracic descending aorta obtained by transesophageal echocardiography was closely correlated with CAVI 35) , evidence for theoretical rationale for CAVI in determining vascular function has not been fully elucidated. Further study is needed to enhance the value of CAVI in the clinical setting.
Aortic stiffness in IHD patients has been reported to be higher than in patients without IHD 8) , and was associated with the severity of coronary atherosclerosis 7) . Previous studies reported that CAVI increased with the number of diseased coronary arteries 21, 22) . In this study, coronary atherosclerosis was evaluated with three different angiographic scores. We found that CAVI was associated with not only the severity of stenosis, but also the extent of coronary atherosclerosis. Arterial stiffness was shown to be associated with the incidence of cardiovascular events 3, 36) and an important predictor of the recurrence of adverse events in post-myocardial infarction patients with impaired left ventricular function 9) . Thus, the determination of arterial stiffness is useful for risk stratification.
The relationship between arterial stiffness and left ventricular structures, such as hypertrophy, has been reported previously 8) ; however, the relation between arterial stiffness and LV systolic function has not been fully elucidated. Only one study has shown that brachial-ankle PWV and pulse pressure in patients with coronary artery stenosis was involved in LVEF 13) , which is in line with our finding of the significant association between increased CAVI and reduced LV systolic dysfunction in IHD patients. Regarding LV diastolic function, several studies have shown a relationship between preclinical LV diastolic dysfunction and CAVI in patients with cardiovascular risk factors 11, 30) , but this has not been evaluated only in patients with IHD. LV systolic and diastolic dysfunction are closely linked, as it was previously reported that LV dysfunction develops before LV systolic dys- 37, 38) . Increased arterial stiffness shifts pressure wave reflections from diastole to systole, and thus augments systolic pressure and decreases diastolic pressure 9) . The elevation of systolic pressure caused LV pulsatile load and led to LV hypertrophy, which is one of the major determinants of LV diastolic dysfunction 39) . In addition, the coronary blood supply may be reduced because of decreased diastolic pressure, and this reduction is more severe in IHD patients, leading to enhanced cardiac fibrosis. In an animal model, it was reported that cardiac dysfunction after acute coronary occlusion is adversely influenced when the heart ejects into a stiff arterial system 40) . Thus, these factors may, at least in part, predispose consecutive LV systolic dysfunction in IHD patients with increased arterial stiffness, independent of other influential factors, such as prior myocardial infarction.
Although we found a negative correlation between CAVI and LVEF in all IHD patients, this relationship in patients with advanced systolic dysfunction sould be interpreted with case, because the formula for measuring CAVI includes PWV, which was affected by LV contractility. A previous study showed a positive correlation between PWV and LVEF in patients with cardiomyopathy (LVEF 40%) 41) ; however, they also showed no significant difference in mean PWV between patients with cardiomyopathy and control patients with preserved LVEF. An explanation for this contradictory finding might lie in the different populations of the studies. The present study evaluated patients with definite coronary artery disease, whose arterial stiffness was expected to be increased. In addition, our finding revealed that LVEF and coronary atherosclerosis were independently associated with CAVI in patients with IHD. Taken together, an explanation for the negative correlation between CAVI and LVEF is that the contribution of increased arterial stiffness in patients with IHD might overwhelm the impact of reduced LV contractility on PWV. Given the relatively small sample size in this study, further research with a large number of patients is needed to confirm the relationship.
There were several limitations of our study. First, based on its cross-sectional study design, the present findings are inherently limited in their ability to eliminate causal relationships between coronary atherosclerosis, LV function, and CAVI. Second, it is well known that antihypertensive agents influence arterial stiffness and LV systolic and diastolic function. In this study, we evaluated the relationship between CAVI and LV systolic and diastolic functions receiving medicines. The possibility that pharmacological therapy has different effects on its relationship cannot be excluded. Third, in the present study, subjects with ABI 0.9 were excluded, because CAVI in these subjects may be inaccurate; however, IHD is closely associated with peripheral artery disease so ABI may be included to evaluate these data in subjects with ABI 0.9. Fourth, with regard to LV diastolic function, although Doppler echocardiography is the best noninvasive tool to confirm diagnosis 42) , cardiac catheterization remains the preferred method to obtain precise data.
In conclusion, the present study demonstrated that, in patients with IHD, CAVI, a new parameter of arterial stiffness, was correlated with the severity of coronary atherosclerosis, and was associated with LV systolic and diastolic function independent of the severity of coronary atherosclerosis. Thus, the determination of arterial stiffness, such as CAVI, may be useful for risk stratification and secondary prevention in patients with IHD.
